These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 15269255)

  • 21. The impact of Abeta-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice.
    Hu L; Wong TP; Côté SL; Bell KF; Cuello AC
    Neuroscience; 2003; 121(2):421-32. PubMed ID: 14522000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of hydroxysteroid dehydrogenase type 10 in amyloid plaques (APs) of Hsiao's APP-Sw transgenic mouse brains, but absence in APs of Alzheimer's disease brains.
    Wen GY; Yang SY; Kaczmarski W; He XY; Pappas KS
    Brain Res; 2002 Nov; 954(1):115-22. PubMed ID: 12393239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
    Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
    Behav Brain Res; 2013 Mar; 240():146-52. PubMed ID: 23178660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-132 regulates the expression of synaptic proteins in APP/PS1 transgenic mice through C1q.
    Xu N; Li AD; Ji LL; Ye Y; Wang ZY; Tong L
    Eur J Histochem; 2019 May; 63(2):. PubMed ID: 31060348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial sepsis increases hippocampal fibrillar amyloid plaque load and neuroinflammation in a mouse model of Alzheimer's disease.
    Basak JM; Ferreiro A; Cohen LS; Sheehan PW; Nadarajah CJ; Kanan MF; Sukhum KV; Dantas G; Musiek ES
    Neurobiol Dis; 2021 May; 152():105292. PubMed ID: 33556539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigations into Retinal Pathology in the Early Stages of a Mouse Model of Alzheimer's Disease.
    Chidlow G; Wood JP; Manavis J; Finnie J; Casson RJ
    J Alzheimers Dis; 2017; 56(2):655-675. PubMed ID: 28035930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration of cortical EEG in mice carrying mutated human APP transgene.
    Wang J; Ikonen S; Gurevicius K; van Groen T; Tanila H
    Brain Res; 2002 Jul; 943(2):181-90. PubMed ID: 12101040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse.
    Ontiveros-Torres MÁ; Labra-Barrios ML; Díaz-Cintra S; Aguilar-Vázquez AR; Moreno-Campuzano S; Flores-Rodríguez P; Luna-Herrera C; Mena R; Perry G; Florán-Garduño B; Luna-Muñoz J; Luna-Arias JP
    J Alzheimers Dis; 2016 Mar; 52(1):243-69. PubMed ID: 27031470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterozygous knockout of cytosolic phospholipase A
    Qu B; Gong Y; Gill JM; Kenney K; Diaz-Arrastia R
    Brain Res; 2017 Sep; 1670():248-252. PubMed ID: 28648388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Terminal complement pathway activation drives synaptic loss in Alzheimer's disease models.
    Carpanini SM; Torvell M; Bevan RJ; Byrne RAJ; Daskoulidou N; Saito T; Saido TC; Taylor PR; Hughes TR; Zelek WM; Morgan BP
    Acta Neuropathol Commun; 2022 Jul; 10(1):99. PubMed ID: 35794654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic deletion of CB
    Aso E; Andrés-Benito P; Ferrer I
    Biochem Pharmacol; 2018 Nov; 157():210-216. PubMed ID: 30096288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
    Ettcheto M; Petrov D; Pedrós I; Alva N; Carbonell T; Beas-Zarate C; Pallas M; Auladell C; Folch J; Camins A
    J Alzheimers Dis; 2016 Jul; 54(1):233-51. PubMed ID: 27567882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
    Kuznetsova E; Schliebs R
    Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.
    Holubová M; Hrubá L; Popelová A; Bencze M; Pražienková V; Gengler S; Kratochvílová H; Haluzík M; Železná B; Kuneš J; Hölscher C; Maletínská L
    Neuropharmacology; 2019 Jan; 144():377-387. PubMed ID: 30428311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model.
    Krauthausen M; Kummer MP; Zimmermann J; Reyes-Irisarri E; Terwel D; Bulic B; Heneka MT; Müller M
    J Clin Invest; 2015 Jan; 125(1):365-78. PubMed ID: 25500888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice.
    Park IH; Hwang EM; Hong HS; Boo JH; Oh SS; Lee J; Jung MW; Bang OY; Kim SU; Mook-Jung I
    Neurobiol Aging; 2003 Sep; 24(5):637-43. PubMed ID: 12885571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer's Disease-Like Pathology.
    Schmöle AC; Lundt R; Toporowski G; Hansen JN; Beins E; Halle A; Zimmer A
    J Alzheimers Dis; 2018; 64(2):379-392. PubMed ID: 29865078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.
    Dewachter I; van Dorpe J; Spittaels K; Tesseur I; Van Den Haute C; Moechars D; Van Leuven F
    Exp Gerontol; 2000 Sep; 35(6-7):831-41. PubMed ID: 11053674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.